Review



anti cd45  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier
Bioz Manufacturer Symbol Bio-Rad manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bio-Rad anti cd45
    Anti Cd45, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 460 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/Rat+anti+Mouse+CD45/pmc03325361-48-4-11
    Average 94 stars, based on 460 article reviews
    anti cd45 - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: Diet-Dependent Modulation of Energy Balance by CB1 Signaling in Peripheral Sensory Neurons
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit anti-UCP1 1:100 ABclonal A5857 Rabbit anti-CB1 1:250 Abcam ab23703 Rat anti-mouse CD68 1:50 Bio-Rad MCA1957GA Rat anti-CD45 1:50 Novus NB100-77417 Rabbit anti-TH 1:200 Phosphosolutions #2025-THRAB Rabbit anti-CGRP 1:1000 Sigma C8198 Rabbit anti-chromogranin A Proteintech 10529-1-AP Alexa 488 donkey anti-rabbit IgG 1:1000 Invitrogen A32790 Alexa 555 goat anti-rabbit IgG 1:1000 Invitrogen A21428 Alexa Fluor 488 donkey anti-rat IgG 1:100 1:1000 Invitrogen A21208 Oligonucleotides Uncoupling protein 1 (Ucp1, FAM dye) IDT Mm.PT.58.7088262Beta Beta-3 adrenergic receptor (Adrb3, FAM) IDT Mm.PT.58.31423945 Adipose triglyceride lipase (Atgl, FAM) IDT Mm.PT.56a.13182140 Agouti-related peptide (Agrp, FAM) IDT Mm.PT.58.45969609.g Neuropeptide Y (Npy, FAM) IDT Mm.PT.58.29444574 Proopiomelanocortin (Pomc, FAM) IDT Mm.PT.58.5917321 Beta-actin (Actb, HEX dye) IDT Mm.PT.39a.22214843 e1 iScience 28, 113124, August 15, 2025

    Immunodepletion:

    Article Title: Mesenchymal Stem/Stromal Cells (MSCs) from Mouse Pelvic vs. Long Bones Exhibit Disparate Critical Quality Attributes: Implications for Translational Studies.
    Article Snippet: .. A single preparation of BML- and BMP-MSCs (2.5 × 105 cells/mL) enriched from bone marrow by immuno-depletion and maintained in 5% O2 was suspended in Hank’s balanced saline solution (HBSS) and incubated with the following fluorochrome conjugated rat antimouse antibodies: FITC-CD11b (Invitrogen, #RM2801, Waltham, MA, USA), FITC-CD34 (BioRad, #MCA1825F, Hercules, CA, USA), FITC-CD45 (BioRad, #MCA1031F), FITC-CD29 (BioLegend, #102206, San Diego, CA, USA), PerCP/Cyanine5.5-CD44 (BioLegend, #103032), PerCP/Cyanine5.5-CD73 (BioLegend, #127214), PerCP/Cyanine5.5-CD105 (BioLegend, #120416) and PE-SCA1 (R & D Systems Inc., #FAB1226P, Minneapolis, MN, USA) for 30 min at 4 ◦C as described previously [32]. .. Cells were washed twice with HBSS and analyzed using an EPICS FC 500 FACS scanner equipped with CXP software (Beckman Coulter, Brea, CA, USA).

    Article Title: Mesenchymal Stem/Stromal Cells (MSCs) from Mouse Pelvic vs. Long Bones Exhibit Disparate Critical Quality Attributes: Implications for Translational Studies
    Article Snippet: .. A single preparation of BM L - and BM P -MSCs (2.5 × 10 5 cells/mL) enriched from bone marrow by immuno-depletion and maintained in 5% O 2 was suspended in Hank’s balanced saline solution (HBSS) and incubated with the following fluorochrome conjugated rat anti-mouse antibodies: FITC-CD11b (Invitrogen, #RM2801, Waltham, MA, USA), FITC-CD34 (BioRad, #MCA1825F, Hercules, CA, USA), FITC-CD45 (BioRad, #MCA1031F), FITC-CD29 (BioLegend, #102206, San Diego, CA, USA), PerCP/Cyanine5.5-CD44 (BioLegend, #103032), PerCP/Cyanine5.5-CD73 (BioLegend, #127214), PerCP/Cyanine5.5-CD105 (BioLegend, #120416) and PE-SCA1 (R & D Systems Inc., #FAB1226P, Minneapolis, MN, USA) for 30 min at 4 °C as described previously [ ]. .. Cells were washed twice with HBSS and analyzed using an EPICS FC 500 FACS scanner equipped with CXP software (Beckman Coulter, Brea, CA, USA).

    Saline:

    Article Title: Mesenchymal Stem/Stromal Cells (MSCs) from Mouse Pelvic vs. Long Bones Exhibit Disparate Critical Quality Attributes: Implications for Translational Studies.
    Article Snippet: .. A single preparation of BML- and BMP-MSCs (2.5 × 105 cells/mL) enriched from bone marrow by immuno-depletion and maintained in 5% O2 was suspended in Hank’s balanced saline solution (HBSS) and incubated with the following fluorochrome conjugated rat antimouse antibodies: FITC-CD11b (Invitrogen, #RM2801, Waltham, MA, USA), FITC-CD34 (BioRad, #MCA1825F, Hercules, CA, USA), FITC-CD45 (BioRad, #MCA1031F), FITC-CD29 (BioLegend, #102206, San Diego, CA, USA), PerCP/Cyanine5.5-CD44 (BioLegend, #103032), PerCP/Cyanine5.5-CD73 (BioLegend, #127214), PerCP/Cyanine5.5-CD105 (BioLegend, #120416) and PE-SCA1 (R & D Systems Inc., #FAB1226P, Minneapolis, MN, USA) for 30 min at 4 ◦C as described previously [32]. .. Cells were washed twice with HBSS and analyzed using an EPICS FC 500 FACS scanner equipped with CXP software (Beckman Coulter, Brea, CA, USA).

    Article Title: Mesenchymal Stem/Stromal Cells (MSCs) from Mouse Pelvic vs. Long Bones Exhibit Disparate Critical Quality Attributes: Implications for Translational Studies
    Article Snippet: .. A single preparation of BM L - and BM P -MSCs (2.5 × 10 5 cells/mL) enriched from bone marrow by immuno-depletion and maintained in 5% O 2 was suspended in Hank’s balanced saline solution (HBSS) and incubated with the following fluorochrome conjugated rat anti-mouse antibodies: FITC-CD11b (Invitrogen, #RM2801, Waltham, MA, USA), FITC-CD34 (BioRad, #MCA1825F, Hercules, CA, USA), FITC-CD45 (BioRad, #MCA1031F), FITC-CD29 (BioLegend, #102206, San Diego, CA, USA), PerCP/Cyanine5.5-CD44 (BioLegend, #103032), PerCP/Cyanine5.5-CD73 (BioLegend, #127214), PerCP/Cyanine5.5-CD105 (BioLegend, #120416) and PE-SCA1 (R & D Systems Inc., #FAB1226P, Minneapolis, MN, USA) for 30 min at 4 °C as described previously [ ]. .. Cells were washed twice with HBSS and analyzed using an EPICS FC 500 FACS scanner equipped with CXP software (Beckman Coulter, Brea, CA, USA).

    Incubation:

    Article Title: Mesenchymal Stem/Stromal Cells (MSCs) from Mouse Pelvic vs. Long Bones Exhibit Disparate Critical Quality Attributes: Implications for Translational Studies.
    Article Snippet: .. A single preparation of BML- and BMP-MSCs (2.5 × 105 cells/mL) enriched from bone marrow by immuno-depletion and maintained in 5% O2 was suspended in Hank’s balanced saline solution (HBSS) and incubated with the following fluorochrome conjugated rat antimouse antibodies: FITC-CD11b (Invitrogen, #RM2801, Waltham, MA, USA), FITC-CD34 (BioRad, #MCA1825F, Hercules, CA, USA), FITC-CD45 (BioRad, #MCA1031F), FITC-CD29 (BioLegend, #102206, San Diego, CA, USA), PerCP/Cyanine5.5-CD44 (BioLegend, #103032), PerCP/Cyanine5.5-CD73 (BioLegend, #127214), PerCP/Cyanine5.5-CD105 (BioLegend, #120416) and PE-SCA1 (R & D Systems Inc., #FAB1226P, Minneapolis, MN, USA) for 30 min at 4 ◦C as described previously [32]. .. Cells were washed twice with HBSS and analyzed using an EPICS FC 500 FACS scanner equipped with CXP software (Beckman Coulter, Brea, CA, USA).

    Article Title: Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia‐Dependent Plaque Response in Aged Mice
    Article Snippet: Microscopy images were obtained with an Olympus VS120 slide scanner. .. For immunofluorescence labeling, sections were incubated with 5% BSA PBS (Sigma‐Aldrich) for 1 h at room temperature, followed by a 24‐h incubation with one or two of the following primary antibodies: 6E10 (mouse monoclonal, 1:5000; BioLegend; Catalog #SIG‐39320), APP (rabbit polyclonal, 1:10000; Sigma‐Aldrich; Catalog #A8717), AT8 (mouse monoclonal, 1:1000; ThermoScientific; Catalog #MN1020), CD45 (rat polyclonal, 1:500; Bio‐Rad; Catalog #MCA1388), CD68 (rabbit polyclonal, 1:1000; Abcam Cambridge, UK; Catalog # AB125212 ), GFAP (rabbit polyclonal, 1:2000; Dako, Santa Clara, CA, USA; Catalog #Z0334), Iba1 (rabbit polyclonal, 1:1000; Wako, Osaka, Japan; Catalog #019–19,741), Iba1 (goat polyclonal, 1:1000; Abcam; Catalog #ab5076), MC1 (mouse monoclonal, 1:500; provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA), P2RY12 (rabbit polyclonal, 1:200; Sigma‐Aldrich; Catalog #HPA014518), PHF1 (mouse monoclonal, 1:500; provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA) or TREM2 (sheep polyclonal, 1:1000; R&D Systems, Abingdon, UK; Catalog #AF1729). .. Next, sections were incubated for 1 h in the corresponding secondary antibody conjugated to Alexa fluorochrome (1:1000; Invitrogen): donkey anti‐goat 488 (Catalog #A11055), donkey anti‐mouse 568 (Catalog #A10037), donkey anti‐rabbit 568 (Catalog #A10042), goat anti‐rabbit 488 (Catalog #A11008), goat anti‐rat 568 (Catalog #A11077) and biotinylated rabbit anti‐sheep (1:500, Vector Labs; Catalog #BA‐6000) which was additionally incubated for another 1 h 15 min with streptavidin Alexa Fluor 488 conjugate (1:500, Invitrogen; Catalog #S32354).

    Article Title: Mesenchymal Stem/Stromal Cells (MSCs) from Mouse Pelvic vs. Long Bones Exhibit Disparate Critical Quality Attributes: Implications for Translational Studies
    Article Snippet: .. A single preparation of BM L - and BM P -MSCs (2.5 × 10 5 cells/mL) enriched from bone marrow by immuno-depletion and maintained in 5% O 2 was suspended in Hank’s balanced saline solution (HBSS) and incubated with the following fluorochrome conjugated rat anti-mouse antibodies: FITC-CD11b (Invitrogen, #RM2801, Waltham, MA, USA), FITC-CD34 (BioRad, #MCA1825F, Hercules, CA, USA), FITC-CD45 (BioRad, #MCA1031F), FITC-CD29 (BioLegend, #102206, San Diego, CA, USA), PerCP/Cyanine5.5-CD44 (BioLegend, #103032), PerCP/Cyanine5.5-CD73 (BioLegend, #127214), PerCP/Cyanine5.5-CD105 (BioLegend, #120416) and PE-SCA1 (R & D Systems Inc., #FAB1226P, Minneapolis, MN, USA) for 30 min at 4 °C as described previously [ ]. .. Cells were washed twice with HBSS and analyzed using an EPICS FC 500 FACS scanner equipped with CXP software (Beckman Coulter, Brea, CA, USA).

    Article Title: Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia-Dependent Plaque Response in Aged Mice.
    Article Snippet: Microscopy images were obtained with an Olympus VS120 slide scanner. .. For immunofluorescence labeling, sections were incubated with 5% BSA PBS (Sigma- Aldrich) for 1 h at room temperature, followed by a 24- h incubation with one or two of the following primary antibodies: 6E10 (mouse monoclonal, 1:5000; BioLegend; Catalog #SIG- 39320), APP (rabbit polyclonal, 1:10000; SigmaAldrich; Catalog #A8717), AT8 (mouse monoclonal, 1:1000; ThermoScientific; Catalog #MN1020), CD45 (rat polyclonal, 1:500; Bio- Rad; Catalog #MCA1388), CD68 (rabbit polyclonal, 1:1000; Abcam Cambridge, UK; Catalog #AB125212), GFAP (rabbit polyclonal, 1:2000; Dako, Santa Clara, CA, USA; Catalog #Z0334), Iba1 (rabbit polyclonal, 1:1000; Wako, Osaka, Japan; Catalog #019–19,741), Iba1 (goat polyclonal, 1:1000; Abcam; Catalog #ab5076), MC1 (mouse monoclonal, 1:500; provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA), P2RY12 (rabbit polyclonal, 1:200; Sigma- Aldrich; Catalog #HPA014518), PHF1 (mouse monoclonal, 1:500; (1)F(t) = Fmax − F0 1 + e− t−t1∕2 k (2)tlag = t1∕2 − 2∕k nloaded from https://onlinelibrary.w iley.com /doi/10.1111/acel.70094 by N guyen T am - T aipei M edical U niversity (T m u) , W iley O nline L ibrary on [18/05/2025]. .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense 7 of 21 provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA) or TREM2 (sheep polyclonal, 1:1000; R&D Systems, Abingdon, UK; Catalog #AF1729).

    Immunofluorescence:

    Article Title: Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia‐Dependent Plaque Response in Aged Mice
    Article Snippet: Microscopy images were obtained with an Olympus VS120 slide scanner. .. For immunofluorescence labeling, sections were incubated with 5% BSA PBS (Sigma‐Aldrich) for 1 h at room temperature, followed by a 24‐h incubation with one or two of the following primary antibodies: 6E10 (mouse monoclonal, 1:5000; BioLegend; Catalog #SIG‐39320), APP (rabbit polyclonal, 1:10000; Sigma‐Aldrich; Catalog #A8717), AT8 (mouse monoclonal, 1:1000; ThermoScientific; Catalog #MN1020), CD45 (rat polyclonal, 1:500; Bio‐Rad; Catalog #MCA1388), CD68 (rabbit polyclonal, 1:1000; Abcam Cambridge, UK; Catalog # AB125212 ), GFAP (rabbit polyclonal, 1:2000; Dako, Santa Clara, CA, USA; Catalog #Z0334), Iba1 (rabbit polyclonal, 1:1000; Wako, Osaka, Japan; Catalog #019–19,741), Iba1 (goat polyclonal, 1:1000; Abcam; Catalog #ab5076), MC1 (mouse monoclonal, 1:500; provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA), P2RY12 (rabbit polyclonal, 1:200; Sigma‐Aldrich; Catalog #HPA014518), PHF1 (mouse monoclonal, 1:500; provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA) or TREM2 (sheep polyclonal, 1:1000; R&D Systems, Abingdon, UK; Catalog #AF1729). .. Next, sections were incubated for 1 h in the corresponding secondary antibody conjugated to Alexa fluorochrome (1:1000; Invitrogen): donkey anti‐goat 488 (Catalog #A11055), donkey anti‐mouse 568 (Catalog #A10037), donkey anti‐rabbit 568 (Catalog #A10042), goat anti‐rabbit 488 (Catalog #A11008), goat anti‐rat 568 (Catalog #A11077) and biotinylated rabbit anti‐sheep (1:500, Vector Labs; Catalog #BA‐6000) which was additionally incubated for another 1 h 15 min with streptavidin Alexa Fluor 488 conjugate (1:500, Invitrogen; Catalog #S32354).

    Article Title: Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia-Dependent Plaque Response in Aged Mice.
    Article Snippet: Microscopy images were obtained with an Olympus VS120 slide scanner. .. For immunofluorescence labeling, sections were incubated with 5% BSA PBS (Sigma- Aldrich) for 1 h at room temperature, followed by a 24- h incubation with one or two of the following primary antibodies: 6E10 (mouse monoclonal, 1:5000; BioLegend; Catalog #SIG- 39320), APP (rabbit polyclonal, 1:10000; SigmaAldrich; Catalog #A8717), AT8 (mouse monoclonal, 1:1000; ThermoScientific; Catalog #MN1020), CD45 (rat polyclonal, 1:500; Bio- Rad; Catalog #MCA1388), CD68 (rabbit polyclonal, 1:1000; Abcam Cambridge, UK; Catalog #AB125212), GFAP (rabbit polyclonal, 1:2000; Dako, Santa Clara, CA, USA; Catalog #Z0334), Iba1 (rabbit polyclonal, 1:1000; Wako, Osaka, Japan; Catalog #019–19,741), Iba1 (goat polyclonal, 1:1000; Abcam; Catalog #ab5076), MC1 (mouse monoclonal, 1:500; provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA), P2RY12 (rabbit polyclonal, 1:200; Sigma- Aldrich; Catalog #HPA014518), PHF1 (mouse monoclonal, 1:500; (1)F(t) = Fmax − F0 1 + e− t−t1∕2 k (2)tlag = t1∕2 − 2∕k nloaded from https://onlinelibrary.w iley.com /doi/10.1111/acel.70094 by N guyen T am - T aipei M edical U niversity (T m u) , W iley O nline L ibrary on [18/05/2025]. .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense 7 of 21 provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA) or TREM2 (sheep polyclonal, 1:1000; R&D Systems, Abingdon, UK; Catalog #AF1729).

    Labeling:

    Article Title: Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia‐Dependent Plaque Response in Aged Mice
    Article Snippet: Microscopy images were obtained with an Olympus VS120 slide scanner. .. For immunofluorescence labeling, sections were incubated with 5% BSA PBS (Sigma‐Aldrich) for 1 h at room temperature, followed by a 24‐h incubation with one or two of the following primary antibodies: 6E10 (mouse monoclonal, 1:5000; BioLegend; Catalog #SIG‐39320), APP (rabbit polyclonal, 1:10000; Sigma‐Aldrich; Catalog #A8717), AT8 (mouse monoclonal, 1:1000; ThermoScientific; Catalog #MN1020), CD45 (rat polyclonal, 1:500; Bio‐Rad; Catalog #MCA1388), CD68 (rabbit polyclonal, 1:1000; Abcam Cambridge, UK; Catalog # AB125212 ), GFAP (rabbit polyclonal, 1:2000; Dako, Santa Clara, CA, USA; Catalog #Z0334), Iba1 (rabbit polyclonal, 1:1000; Wako, Osaka, Japan; Catalog #019–19,741), Iba1 (goat polyclonal, 1:1000; Abcam; Catalog #ab5076), MC1 (mouse monoclonal, 1:500; provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA), P2RY12 (rabbit polyclonal, 1:200; Sigma‐Aldrich; Catalog #HPA014518), PHF1 (mouse monoclonal, 1:500; provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA) or TREM2 (sheep polyclonal, 1:1000; R&D Systems, Abingdon, UK; Catalog #AF1729). .. Next, sections were incubated for 1 h in the corresponding secondary antibody conjugated to Alexa fluorochrome (1:1000; Invitrogen): donkey anti‐goat 488 (Catalog #A11055), donkey anti‐mouse 568 (Catalog #A10037), donkey anti‐rabbit 568 (Catalog #A10042), goat anti‐rabbit 488 (Catalog #A11008), goat anti‐rat 568 (Catalog #A11077) and biotinylated rabbit anti‐sheep (1:500, Vector Labs; Catalog #BA‐6000) which was additionally incubated for another 1 h 15 min with streptavidin Alexa Fluor 488 conjugate (1:500, Invitrogen; Catalog #S32354).

    Article Title: Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia-Dependent Plaque Response in Aged Mice.
    Article Snippet: Microscopy images were obtained with an Olympus VS120 slide scanner. .. For immunofluorescence labeling, sections were incubated with 5% BSA PBS (Sigma- Aldrich) for 1 h at room temperature, followed by a 24- h incubation with one or two of the following primary antibodies: 6E10 (mouse monoclonal, 1:5000; BioLegend; Catalog #SIG- 39320), APP (rabbit polyclonal, 1:10000; SigmaAldrich; Catalog #A8717), AT8 (mouse monoclonal, 1:1000; ThermoScientific; Catalog #MN1020), CD45 (rat polyclonal, 1:500; Bio- Rad; Catalog #MCA1388), CD68 (rabbit polyclonal, 1:1000; Abcam Cambridge, UK; Catalog #AB125212), GFAP (rabbit polyclonal, 1:2000; Dako, Santa Clara, CA, USA; Catalog #Z0334), Iba1 (rabbit polyclonal, 1:1000; Wako, Osaka, Japan; Catalog #019–19,741), Iba1 (goat polyclonal, 1:1000; Abcam; Catalog #ab5076), MC1 (mouse monoclonal, 1:500; provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA), P2RY12 (rabbit polyclonal, 1:200; Sigma- Aldrich; Catalog #HPA014518), PHF1 (mouse monoclonal, 1:500; (1)F(t) = Fmax − F0 1 + e− t−t1∕2 k (2)tlag = t1∕2 − 2∕k nloaded from https://onlinelibrary.w iley.com /doi/10.1111/acel.70094 by N guyen T am - T aipei M edical U niversity (T m u) , W iley O nline L ibrary on [18/05/2025]. .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense 7 of 21 provided by Peter Davies, Albert Einstein College of Medicine, Manhasset, NY, USA) or TREM2 (sheep polyclonal, 1:1000; R&D Systems, Abingdon, UK; Catalog #AF1729).



    Similar Products

    90
    NSJ Bioreagents cd45 antibody
    Cd45 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/CD45+Antibody/custom%40v2394%4042993085
    Average 90 stars, based on 1 article reviews
    cd45 antibody - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec mouse cd45 microbeads
    (A) Young (9-week-old) and aged (90-week-old) mice received vehicle control or lipopolysaccharide (LPS) 24 h before euthanasia. Hearts were collected, retrogradely perfused, and enzymatically dissociated to isolate extravascular CD45⁺ cardiac immune cells. Cells were labeled with TotalSeq™ hashtag oligonucleotide (HTO) antibodies and multiplexed for single-cell RNA sequencing (scRNA-seq), with n = 4 biological replicates per experimental group at the start of the study. (B) Single-cell libraries were generated using the 10x Genomics Chromium Single Cell 3′ Gene Expression platform, followed by Illumina sequencing and Cell Ranger processing to generate gene-expression and HTO feature-barcode matrices. (C) Downstream analyses included HTO demultiplexing, hashtag-based doublet removal, quality-control (QC) filtering, clustering, and cell-type annotation. Pseudobulk differential-expression analysis using the age × LPS interaction term was subsequently performed to identify cell type-specific aging-dependent transcriptional responses to LPS. *One Aged-LPS biological replicate was excluded from downstream analysis because the mouse experienced cardiac arrest before euthanasia, representing a potential biological confounder. The final sample size analyzed was therefore n = 4 for Young-control, Young-LPS, and Aged-control groups and n = 3 for the Aged-LPS group.
    Mouse Cd45 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/CD45+MicroBeads%2C+mouse/bio_rxiv__64898__2026__11__02__763785-51-17-20
    Average 97 stars, based on 1 article reviews
    mouse cd45 microbeads - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    Novus Biologicals dylight 650
    (A) Young (9-week-old) and aged (90-week-old) mice received vehicle control or lipopolysaccharide (LPS) 24 h before euthanasia. Hearts were collected, retrogradely perfused, and enzymatically dissociated to isolate extravascular CD45⁺ cardiac immune cells. Cells were labeled with TotalSeq™ hashtag oligonucleotide (HTO) antibodies and multiplexed for single-cell RNA sequencing (scRNA-seq), with n = 4 biological replicates per experimental group at the start of the study. (B) Single-cell libraries were generated using the 10x Genomics Chromium Single Cell 3′ Gene Expression platform, followed by Illumina sequencing and Cell Ranger processing to generate gene-expression and HTO feature-barcode matrices. (C) Downstream analyses included HTO demultiplexing, hashtag-based doublet removal, quality-control (QC) filtering, clustering, and cell-type annotation. Pseudobulk differential-expression analysis using the age × LPS interaction term was subsequently performed to identify cell type-specific aging-dependent transcriptional responses to LPS. *One Aged-LPS biological replicate was excluded from downstream analysis because the mouse experienced cardiac arrest before euthanasia, representing a potential biological confounder. The final sample size analyzed was therefore n = 4 for Young-control, Young-LPS, and Aged-control groups and n = 3 for the Aged-LPS group.
    Dylight 650, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/CD45+Antibody+(30-F11)+%5BDyLight+650%5D/pmc13760287-75-6-12
    Average 94 stars, based on 1 article reviews
    dylight 650 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Novus Biologicals dylight 650 conjugated anti cd45
    Therapeutic effects on inflammatory cell infiltration. ( A ) Representative OCT images of the anterior chamber 10 days post-alkali burn, including healthy, alkali burn only (untreated), and treatment with aflibercept or anti–Scg3 hAb, respectively. ( B ) H&E images showing leukocyte infiltration ( red arrows ) in the corneas, day 10 post-injury ( n = 3 corneas). ( C , D ) Images showing flow cytometry data ( C ) and quantification of <t>CD45</t> + cells ( D ) on day 3 after alkali burn ( n = 3 samples per group; 5 corneas pooled per sample). ( E , F ) Immunofluorescence images of corneas stained with <t>anti-CD45</t> ( E ), and the quantified number of CD45 + cells ( F ) ( n = 3 corneas). Scale bar : 50 µm. ( G , H ) Graphs showing mRNA expression of IL-1α ( G ) and TGF-β ( H ) ( n = 3 samples per group; 5 corneas pooled per sample). Data are presented as ±SEM. P < 0.05 (one-way ANOVA).
    Dylight 650 Conjugated Anti Cd45, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/CD45+Antibody+(30-F11)+-+BSA+Free/pmc13760287-47-30-37
    Average 93 stars, based on 1 article reviews
    dylight 650 conjugated anti cd45 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Novus Biologicals anti mouse cd45 af 647 em 05
    Therapeutic effects on inflammatory cell infiltration. ( A ) Representative OCT images of the anterior chamber 10 days post-alkali burn, including healthy, alkali burn only (untreated), and treatment with aflibercept or anti–Scg3 hAb, respectively. ( B ) H&E images showing leukocyte infiltration ( red arrows ) in the corneas, day 10 post-injury ( n = 3 corneas). ( C , D ) Images showing flow cytometry data ( C ) and quantification of <t>CD45</t> + cells ( D ) on day 3 after alkali burn ( n = 3 samples per group; 5 corneas pooled per sample). ( E , F ) Immunofluorescence images of corneas stained with <t>anti-CD45</t> ( E ), and the quantified number of CD45 + cells ( F ) ( n = 3 corneas). Scale bar : 50 µm. ( G , H ) Graphs showing mRNA expression of IL-1α ( G ) and TGF-β ( H ) ( n = 3 samples per group; 5 corneas pooled per sample). Data are presented as ±SEM. P < 0.05 (one-way ANOVA).
    Anti Mouse Cd45 Af 647 Em 05, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/CD45+Antibody+(EM-05)+%5BAlexa+Fluor%C2%AE+647%5D/pm42982037-856-70-75
    Average 94 stars, based on 1 article reviews
    anti mouse cd45 af 647 em 05 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti cd45 2
    Therapeutic effects on inflammatory cell infiltration. ( A ) Representative OCT images of the anterior chamber 10 days post-alkali burn, including healthy, alkali burn only (untreated), and treatment with aflibercept or anti–Scg3 hAb, respectively. ( B ) H&E images showing leukocyte infiltration ( red arrows ) in the corneas, day 10 post-injury ( n = 3 corneas). ( C , D ) Images showing flow cytometry data ( C ) and quantification of <t>CD45</t> + cells ( D ) on day 3 after alkali burn ( n = 3 samples per group; 5 corneas pooled per sample). ( E , F ) Immunofluorescence images of corneas stained with <t>anti-CD45</t> ( E ), and the quantified number of CD45 + cells ( F ) ( n = 3 corneas). Scale bar : 50 µm. ( G , H ) Graphs showing mRNA expression of IL-1α ( G ) and TGF-β ( H ) ( n = 3 samples per group; 5 corneas pooled per sample). Data are presented as ±SEM. P < 0.05 (one-way ANOVA).
    Anti Cd45 2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/CD45%2E2+Antibody%2C+anti-mouse/bio_rxiv__64898__2026__11__03__763975-67-27-28
    Average 94 stars, based on 1 article reviews
    anti cd45 2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc rabbit monoclonal anti cd45
    Therapeutic effects on inflammatory cell infiltration. ( A ) Representative OCT images of the anterior chamber 10 days post-alkali burn, including healthy, alkali burn only (untreated), and treatment with aflibercept or anti–Scg3 hAb, respectively. ( B ) H&E images showing leukocyte infiltration ( red arrows ) in the corneas, day 10 post-injury ( n = 3 corneas). ( C , D ) Images showing flow cytometry data ( C ) and quantification of <t>CD45</t> + cells ( D ) on day 3 after alkali burn ( n = 3 samples per group; 5 corneas pooled per sample). ( E , F ) Immunofluorescence images of corneas stained with <t>anti-CD45</t> ( E ), and the quantified number of CD45 + cells ( F ) ( n = 3 corneas). Scale bar : 50 µm. ( G , H ) Graphs showing mRNA expression of IL-1α ( G ) and TGF-β ( H ) ( n = 3 samples per group; 5 corneas pooled per sample). Data are presented as ±SEM. P < 0.05 (one-way ANOVA).
    Rabbit Monoclonal Anti Cd45, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/CD45+Rabbit+mAb/pm42981186-194-238-241
    Average 96 stars, based on 1 article reviews
    rabbit monoclonal anti cd45 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Illumina Inc genomics 1000212 cosmx human rna 1000 plex assay nanostring cmx h uscp 1kp r infiniumcoreexome 24v1 4 a1 illumina 20024662 human io panck cd45
    Therapeutic effects on inflammatory cell infiltration. ( A ) Representative OCT images of the anterior chamber 10 days post-alkali burn, including healthy, alkali burn only (untreated), and treatment with aflibercept or anti–Scg3 hAb, respectively. ( B ) H&E images showing leukocyte infiltration ( red arrows ) in the corneas, day 10 post-injury ( n = 3 corneas). ( C , D ) Images showing flow cytometry data ( C ) and quantification of <t>CD45</t> + cells ( D ) on day 3 after alkali burn ( n = 3 samples per group; 5 corneas pooled per sample). ( E , F ) Immunofluorescence images of corneas stained with <t>anti-CD45</t> ( E ), and the quantified number of CD45 + cells ( F ) ( n = 3 corneas). Scale bar : 50 µm. ( G , H ) Graphs showing mRNA expression of IL-1α ( G ) and TGF-β ( H ) ( n = 3 samples per group; 5 corneas pooled per sample). Data are presented as ±SEM. P < 0.05 (one-way ANOVA).
    Genomics 1000212 Cosmx Human Rna 1000 Plex Assay Nanostring Cmx H Uscp 1kp R Infiniumcoreexome 24v1 4 A1 Illumina 20024662 Human Io Panck Cd45, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/Infinium+CoreExome-24+v1%2E3+Kit/pm42986753-290-163-173
    Average 94 stars, based on 1 article reviews
    genomics 1000212 cosmx human rna 1000 plex assay nanostring cmx h uscp 1kp r infiniumcoreexome 24v1 4 a1 illumina 20024662 human io panck cd45 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec antibodies against human cd45
    a. Leukemic burden in T-ALL PDX1 mice, measured as the percentage of <t>human</t> <t>CD45-positive</t> (hCD45⁺) cells in peripheral blood during treatment with ASNase (25 IU/mouse every 8 days) for 5 weeks. Treatment was discontinued following sacrifice of the vehicle-treated mice, and the remaining mice were monitored until reaching the experimental endpoint. Each dot represents an individual mouse. b. Bodyweight of mice shown in , expressed as the percentage of baseline bodyweight. Dots represent group means; error bars indicate SEM.
    Antibodies Against Human Cd45, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/CD45+Antibody%2C+anti-human%2C+REAfinity/bio_rxiv__64898__2026__11__02__763650-299-18-22
    Average 96 stars, based on 1 article reviews
    antibodies against human cd45 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    Precision X-Ray recipient mice cd45 1
    ( A-B ) Bone marrow cellularity and the frequencies of hematopoietic stem cells, progenitors, and mature cells in bone marrow of LysMCre;Slc23a2 Δ/Δ and littermate control mice at 8 weeks of age. ( C-E ) Competitive transplant to assess ascorbate-deficient HPC-1 reconstitution function. 1,000 HPC-1 (CD45.2) from Mx1Cre;Slc23a2 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow <t>(CD45.1;CD45.2)</t> cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 13 recipient mice/genotype from 3 donors/genotype). ( D-E ) Donor chimerism of myeloid progenitors in bone marrow and spleen, and mature cells in bone marrow and blood 14-15 days after transplant. ( F-G ) Competitive transplantation to assess ascorbate-deficient CMP reconstitution function. 5,000 CMPs (CD45.2) from Mx1Cre;Slc23a2 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 13-14 recipient mice/genotype from 3 donors/genotype). ( G ) Donor chimerism of mature cells in bone marrow, spleen and blood 12-14 days after transplant.
    Recipient Mice Cd45 1, supplied by Precision X-Ray, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd45/X-Rad320/bio_rxiv__64898__2026__10__27__762224-199-0-12
    Average 98 stars, based on 1 article reviews
    recipient mice cd45 1 - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    Image Search Results


    (A) Young (9-week-old) and aged (90-week-old) mice received vehicle control or lipopolysaccharide (LPS) 24 h before euthanasia. Hearts were collected, retrogradely perfused, and enzymatically dissociated to isolate extravascular CD45⁺ cardiac immune cells. Cells were labeled with TotalSeq™ hashtag oligonucleotide (HTO) antibodies and multiplexed for single-cell RNA sequencing (scRNA-seq), with n = 4 biological replicates per experimental group at the start of the study. (B) Single-cell libraries were generated using the 10x Genomics Chromium Single Cell 3′ Gene Expression platform, followed by Illumina sequencing and Cell Ranger processing to generate gene-expression and HTO feature-barcode matrices. (C) Downstream analyses included HTO demultiplexing, hashtag-based doublet removal, quality-control (QC) filtering, clustering, and cell-type annotation. Pseudobulk differential-expression analysis using the age × LPS interaction term was subsequently performed to identify cell type-specific aging-dependent transcriptional responses to LPS. *One Aged-LPS biological replicate was excluded from downstream analysis because the mouse experienced cardiac arrest before euthanasia, representing a potential biological confounder. The final sample size analyzed was therefore n = 4 for Young-control, Young-LPS, and Aged-control groups and n = 3 for the Aged-LPS group.

    Journal: bioRxiv

    Article Title: Aging reshapes cardiac extravascular leukocyte transcription through bidirectional remodeling during LPS-induced endotoxemia

    doi: 10.64898/2026.11.02.763785

    Figure Lengend Snippet: (A) Young (9-week-old) and aged (90-week-old) mice received vehicle control or lipopolysaccharide (LPS) 24 h before euthanasia. Hearts were collected, retrogradely perfused, and enzymatically dissociated to isolate extravascular CD45⁺ cardiac immune cells. Cells were labeled with TotalSeq™ hashtag oligonucleotide (HTO) antibodies and multiplexed for single-cell RNA sequencing (scRNA-seq), with n = 4 biological replicates per experimental group at the start of the study. (B) Single-cell libraries were generated using the 10x Genomics Chromium Single Cell 3′ Gene Expression platform, followed by Illumina sequencing and Cell Ranger processing to generate gene-expression and HTO feature-barcode matrices. (C) Downstream analyses included HTO demultiplexing, hashtag-based doublet removal, quality-control (QC) filtering, clustering, and cell-type annotation. Pseudobulk differential-expression analysis using the age × LPS interaction term was subsequently performed to identify cell type-specific aging-dependent transcriptional responses to LPS. *One Aged-LPS biological replicate was excluded from downstream analysis because the mouse experienced cardiac arrest before euthanasia, representing a potential biological confounder. The final sample size analyzed was therefore n = 4 for Young-control, Young-LPS, and Aged-control groups and n = 3 for the Aged-LPS group.

    Article Snippet: The cells were washed and resuspended in MACS buffer (Miltenyi Biotec), followed by enrichment of leukocytes using mouse CD45 MicroBeads (Miltenyi Biotec, 130-052-301) according to the manufacturer’s protocol.

    Techniques: Control, Labeling, Single Cell, RNA Sequencing, Generated, Gene Expression, Illumina Sequencing, QC/EQA/Proficiency, Quantitative Proteomics, Analysis

    Therapeutic effects on inflammatory cell infiltration. ( A ) Representative OCT images of the anterior chamber 10 days post-alkali burn, including healthy, alkali burn only (untreated), and treatment with aflibercept or anti–Scg3 hAb, respectively. ( B ) H&E images showing leukocyte infiltration ( red arrows ) in the corneas, day 10 post-injury ( n = 3 corneas). ( C , D ) Images showing flow cytometry data ( C ) and quantification of CD45 + cells ( D ) on day 3 after alkali burn ( n = 3 samples per group; 5 corneas pooled per sample). ( E , F ) Immunofluorescence images of corneas stained with anti-CD45 ( E ), and the quantified number of CD45 + cells ( F ) ( n = 3 corneas). Scale bar : 50 µm. ( G , H ) Graphs showing mRNA expression of IL-1α ( G ) and TGF-β ( H ) ( n = 3 samples per group; 5 corneas pooled per sample). Data are presented as ±SEM. P < 0.05 (one-way ANOVA).

    Journal: Investigative Ophthalmology & Visual Science

    Article Title: Subconjunctival Injection of Anti-Secretogranin III Mitigates Corneal Damage in Alkali Burn Injury Model

    doi: 10.1167/iovs.67.13.15

    Figure Lengend Snippet: Therapeutic effects on inflammatory cell infiltration. ( A ) Representative OCT images of the anterior chamber 10 days post-alkali burn, including healthy, alkali burn only (untreated), and treatment with aflibercept or anti–Scg3 hAb, respectively. ( B ) H&E images showing leukocyte infiltration ( red arrows ) in the corneas, day 10 post-injury ( n = 3 corneas). ( C , D ) Images showing flow cytometry data ( C ) and quantification of CD45 + cells ( D ) on day 3 after alkali burn ( n = 3 samples per group; 5 corneas pooled per sample). ( E , F ) Immunofluorescence images of corneas stained with anti-CD45 ( E ), and the quantified number of CD45 + cells ( F ) ( n = 3 corneas). Scale bar : 50 µm. ( G , H ) Graphs showing mRNA expression of IL-1α ( G ) and TGF-β ( H ) ( n = 3 samples per group; 5 corneas pooled per sample). Data are presented as ±SEM. P < 0.05 (one-way ANOVA).

    Article Snippet: The slides were then incubated with primary antibodies, including anti–fibronectin (ab2413, 1:500 dilution; Abcam, Cambridge, UK), anti–α-smooth muscle actin (α-SMA; SC56495, 1:500 dilution; Santa Cruz Biotechnology, Dallas, TX, USA), or DyLight 650 conjugated anti-CD45 (NB100-77417, 1:500 dilution; Novus Biologicals, Centennial, CO, USA), at 4°C overnight.

    Techniques: Flow Cytometry, Immunofluorescence, Staining, Expressing

    a. Leukemic burden in T-ALL PDX1 mice, measured as the percentage of human CD45-positive (hCD45⁺) cells in peripheral blood during treatment with ASNase (25 IU/mouse every 8 days) for 5 weeks. Treatment was discontinued following sacrifice of the vehicle-treated mice, and the remaining mice were monitored until reaching the experimental endpoint. Each dot represents an individual mouse. b. Bodyweight of mice shown in , expressed as the percentage of baseline bodyweight. Dots represent group means; error bars indicate SEM.

    Journal: bioRxiv

    Article Title: PERTURBATION OF THE AMINO ACID STRESS RESPONSE PATHWAY EXPOSES A METABOLIC VULNERABILITY IN MULTIPLE AGGRESSIVE CANCER SUBTYPES

    doi: 10.64898/2026.11.02.763650

    Figure Lengend Snippet: a. Leukemic burden in T-ALL PDX1 mice, measured as the percentage of human CD45-positive (hCD45⁺) cells in peripheral blood during treatment with ASNase (25 IU/mouse every 8 days) for 5 weeks. Treatment was discontinued following sacrifice of the vehicle-treated mice, and the remaining mice were monitored until reaching the experimental endpoint. Each dot represents an individual mouse. b. Bodyweight of mice shown in , expressed as the percentage of baseline bodyweight. Dots represent group means; error bars indicate SEM.

    Article Snippet: Red blood cells were lysed using ACK lysis buffer (Gibco, #A1049201) , and remaining cells were stained using antibodies against human CD45 (Miltenyi Biotech, #130-110-632) or human CD19 (#12-0199-42).

    Techniques:

    a. Relative viability of leukemic cells isolated from mice treated with a single intravenous dose of ASNase (100 IU/mouse) or vehicle (n = 3 mice per group). Cells were treated ex vivo with a two-fold serial dilution of ASNase (maximum concentration 2000 mIU/mL) for 72 h before viability was assessed using CellTiter-Glo. Concentrations were log-transformed. Each dot represents the mean of three biological replicates; error bars indicate SD. b. Relative ASNS mRNA expression in leukemic cells isolated from mice in (a) treated with ASNase or vehicle. Error bars indicate SEM. **p = 0.0038 (unpaired two-tailed t-test). c. Relative ATF4 mRNA expression in leukemic cells isolated from mice in (a) treated with ASNase or vehicle. Error bars indicate SEM. *p = 0.0238 (unpaired two-tailed t-test). d. Automated capillary western blot (WES) showing ASNS protein expression in leukemic cells isolated from mice in a treated with ASNase or vehicle. β-Actin serves as the loading control. Each lane is a biological replicate. e. Leukemic burden in T-ALL PDX1 mice, measured as the percentage of human CD45-positive (hCD45⁺) cells in peripheral blood. Mice received vehicle, ASNase (25 IU/mouse, single dose; n = 3), GCN2-IN-6 (3 mg/kg, oral dose every 3.5 days; n = 3), or the combination (n = 3). No significant differences were observed between treatment groups before treatment (day 0). At day 7, all treatment groups showed reduced leukemic burden compared with vehicle (*p = 0.0300 for ASNase, **p = 0.0017 for GCN2-IN-6, ***p = 0.0009 for the combination; one-way ANOVA with Dunnett’s multiple-comparison correction). Dots represent group means; error bars indicate SEM.

    Journal: bioRxiv

    Article Title: PERTURBATION OF THE AMINO ACID STRESS RESPONSE PATHWAY EXPOSES A METABOLIC VULNERABILITY IN MULTIPLE AGGRESSIVE CANCER SUBTYPES

    doi: 10.64898/2026.11.02.763650

    Figure Lengend Snippet: a. Relative viability of leukemic cells isolated from mice treated with a single intravenous dose of ASNase (100 IU/mouse) or vehicle (n = 3 mice per group). Cells were treated ex vivo with a two-fold serial dilution of ASNase (maximum concentration 2000 mIU/mL) for 72 h before viability was assessed using CellTiter-Glo. Concentrations were log-transformed. Each dot represents the mean of three biological replicates; error bars indicate SD. b. Relative ASNS mRNA expression in leukemic cells isolated from mice in (a) treated with ASNase or vehicle. Error bars indicate SEM. **p = 0.0038 (unpaired two-tailed t-test). c. Relative ATF4 mRNA expression in leukemic cells isolated from mice in (a) treated with ASNase or vehicle. Error bars indicate SEM. *p = 0.0238 (unpaired two-tailed t-test). d. Automated capillary western blot (WES) showing ASNS protein expression in leukemic cells isolated from mice in a treated with ASNase or vehicle. β-Actin serves as the loading control. Each lane is a biological replicate. e. Leukemic burden in T-ALL PDX1 mice, measured as the percentage of human CD45-positive (hCD45⁺) cells in peripheral blood. Mice received vehicle, ASNase (25 IU/mouse, single dose; n = 3), GCN2-IN-6 (3 mg/kg, oral dose every 3.5 days; n = 3), or the combination (n = 3). No significant differences were observed between treatment groups before treatment (day 0). At day 7, all treatment groups showed reduced leukemic burden compared with vehicle (*p = 0.0300 for ASNase, **p = 0.0017 for GCN2-IN-6, ***p = 0.0009 for the combination; one-way ANOVA with Dunnett’s multiple-comparison correction). Dots represent group means; error bars indicate SEM.

    Article Snippet: Red blood cells were lysed using ACK lysis buffer (Gibco, #A1049201) , and remaining cells were stained using antibodies against human CD45 (Miltenyi Biotech, #130-110-632) or human CD19 (#12-0199-42).

    Techniques: Isolation, Ex Vivo, Serial Dilution, Concentration Assay, Transformation Assay, Expressing, Two Tailed Test, Automated, Western Blot, Control, Comparison

    a-d. Leukemic burden, measured as the percentage of human CD45-positive (hCD45⁺) cells in peripheral blood, in T-ALL PDX models 1–4 treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 6 mice per group). Treatment was discontinued once vehicle-treated mice reached the experimental endpoint, and the remaining mice were monitored for survival. Survival was analyzed using the Kaplan-Meier method with log-rank (Mantel-Cox) testing. Significance is indicated in the figure. e-f. Leukemic burden, measured as the percentage of human CD19-positive (hCD19⁺) cells in peripheral blood, in B-ALL PDX models 1 and 2 treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 6 mice per group). Treatment was discontinued once vehicle-treated mice reached the experimental endpoint, and the remaining mice were monitored for survival. Survival was analyzed using the Kaplan-Meier method with log-rank (Mantel-Cox) testing. Significance is indicated in the figure. g. Spleen weight of AML PDX-bearing mice treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 7 mice per group). Spleens were collected at the experimental endpoint. Statistical significance was determined using the Kruskal-Wallis test. **p = 0.0012. h. Leukemic burden, measured as the percentage of hCD45⁺ cells in peripheral blood, in the AML PDX model following treatment with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 7 mice per group). Statistical analysis was performed using a linear mixed-effects model (REML) with time and treatment as fixed effects. *p = 0.0325. i. Relative tumor growth of an ovarian cancer cell line-derived xenograft (CDX) treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 6 mice per group). Statistical analysis was performed using a linear mixed-effects model (REML). ***p = 0.0008 j. Tumor volume of a neuroblastoma PDX treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 4 per group). Statistical analysis was performed using a linear mixed-effects model (REML). ***p = 0.0002. k – n. Relative tumor growth of four TNBC PDX models treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 5 mice per group). Dots represent group means; error bars indicate SEM. Statistical analysis was performed using a linear mixed-effects model (REML). Significance is indicated in the figure.

    Journal: bioRxiv

    Article Title: PERTURBATION OF THE AMINO ACID STRESS RESPONSE PATHWAY EXPOSES A METABOLIC VULNERABILITY IN MULTIPLE AGGRESSIVE CANCER SUBTYPES

    doi: 10.64898/2026.11.02.763650

    Figure Lengend Snippet: a-d. Leukemic burden, measured as the percentage of human CD45-positive (hCD45⁺) cells in peripheral blood, in T-ALL PDX models 1–4 treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 6 mice per group). Treatment was discontinued once vehicle-treated mice reached the experimental endpoint, and the remaining mice were monitored for survival. Survival was analyzed using the Kaplan-Meier method with log-rank (Mantel-Cox) testing. Significance is indicated in the figure. e-f. Leukemic burden, measured as the percentage of human CD19-positive (hCD19⁺) cells in peripheral blood, in B-ALL PDX models 1 and 2 treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 6 mice per group). Treatment was discontinued once vehicle-treated mice reached the experimental endpoint, and the remaining mice were monitored for survival. Survival was analyzed using the Kaplan-Meier method with log-rank (Mantel-Cox) testing. Significance is indicated in the figure. g. Spleen weight of AML PDX-bearing mice treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 7 mice per group). Spleens were collected at the experimental endpoint. Statistical significance was determined using the Kruskal-Wallis test. **p = 0.0012. h. Leukemic burden, measured as the percentage of hCD45⁺ cells in peripheral blood, in the AML PDX model following treatment with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 7 mice per group). Statistical analysis was performed using a linear mixed-effects model (REML) with time and treatment as fixed effects. *p = 0.0325. i. Relative tumor growth of an ovarian cancer cell line-derived xenograft (CDX) treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 6 mice per group). Statistical analysis was performed using a linear mixed-effects model (REML). ***p = 0.0008 j. Tumor volume of a neuroblastoma PDX treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 4 per group). Statistical analysis was performed using a linear mixed-effects model (REML). ***p = 0.0002. k – n. Relative tumor growth of four TNBC PDX models treated with vehicle or GCN2-IN-6 (3 mg/kg, orally, twice weekly; n = 5 mice per group). Dots represent group means; error bars indicate SEM. Statistical analysis was performed using a linear mixed-effects model (REML). Significance is indicated in the figure.

    Article Snippet: Red blood cells were lysed using ACK lysis buffer (Gibco, #A1049201) , and remaining cells were stained using antibodies against human CD45 (Miltenyi Biotech, #130-110-632) or human CD19 (#12-0199-42).

    Techniques: Analysis, Derivative Assay, Xenograft Assay

    ( A-B ) Bone marrow cellularity and the frequencies of hematopoietic stem cells, progenitors, and mature cells in bone marrow of LysMCre;Slc23a2 Δ/Δ and littermate control mice at 8 weeks of age. ( C-E ) Competitive transplant to assess ascorbate-deficient HPC-1 reconstitution function. 1,000 HPC-1 (CD45.2) from Mx1Cre;Slc23a2 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 13 recipient mice/genotype from 3 donors/genotype). ( D-E ) Donor chimerism of myeloid progenitors in bone marrow and spleen, and mature cells in bone marrow and blood 14-15 days after transplant. ( F-G ) Competitive transplantation to assess ascorbate-deficient CMP reconstitution function. 5,000 CMPs (CD45.2) from Mx1Cre;Slc23a2 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 13-14 recipient mice/genotype from 3 donors/genotype). ( G ) Donor chimerism of mature cells in bone marrow, spleen and blood 12-14 days after transplant.

    Journal: bioRxiv

    Article Title: Ascorbate and TET2 couple balanced hematopoiesis to disease tolerance

    doi: 10.64898/2026.10.27.762224

    Figure Lengend Snippet: ( A-B ) Bone marrow cellularity and the frequencies of hematopoietic stem cells, progenitors, and mature cells in bone marrow of LysMCre;Slc23a2 Δ/Δ and littermate control mice at 8 weeks of age. ( C-E ) Competitive transplant to assess ascorbate-deficient HPC-1 reconstitution function. 1,000 HPC-1 (CD45.2) from Mx1Cre;Slc23a2 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 13 recipient mice/genotype from 3 donors/genotype). ( D-E ) Donor chimerism of myeloid progenitors in bone marrow and spleen, and mature cells in bone marrow and blood 14-15 days after transplant. ( F-G ) Competitive transplantation to assess ascorbate-deficient CMP reconstitution function. 5,000 CMPs (CD45.2) from Mx1Cre;Slc23a2 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 13-14 recipient mice/genotype from 3 donors/genotype). ( G ) Donor chimerism of mature cells in bone marrow, spleen and blood 12-14 days after transplant.

    Article Snippet: Recipient mice (CD45.1) were lethally irradiated using an XRAD 320 X-ray irradiator (Precision X-Ray) with two doses of 5.4 Gy (10.8 Gy total) delivered at least 3 hours apart.

    Techniques: Control, Irradiation, Transplantation Assay

    ( A ) Ascorbate enhances Tet catalytic activity and promotes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) on DNA. ( B ) 5hmC:5mC and 5mC:C ratio on DNA of sorted HSCs and progenitors from mice with the indicated genotypes. +/+ refers to littermate control mice carrying corresponding floxed alleles. ( C-D ) Frequencies of HSPCs and myeloid cells in from mice with the indicated genotypes. ( E-F ) Frequencies of erythroid progenitors in bone marrow and spleen. ( G-H ) Competitive transplantation to assess Tet2;Tet3 -deficient CMP reconstitution function. 5,000 CMPs (CD45.2) from Mx1Cre;Tet2 Δ/Δ ;Tet3 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 11-14 recipient mice/genotype from 3 donors/genotype). ( H ) Donor chimerism of mature cells in bone marrow, spleen and blood 12 days after CMP transplant.

    Journal: bioRxiv

    Article Title: Ascorbate and TET2 couple balanced hematopoiesis to disease tolerance

    doi: 10.64898/2026.10.27.762224

    Figure Lengend Snippet: ( A ) Ascorbate enhances Tet catalytic activity and promotes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) on DNA. ( B ) 5hmC:5mC and 5mC:C ratio on DNA of sorted HSCs and progenitors from mice with the indicated genotypes. +/+ refers to littermate control mice carrying corresponding floxed alleles. ( C-D ) Frequencies of HSPCs and myeloid cells in from mice with the indicated genotypes. ( E-F ) Frequencies of erythroid progenitors in bone marrow and spleen. ( G-H ) Competitive transplantation to assess Tet2;Tet3 -deficient CMP reconstitution function. 5,000 CMPs (CD45.2) from Mx1Cre;Tet2 Δ/Δ ;Tet3 Δ/Δ or littermate control mice were mixed with 400,000 competitor bone marrow (CD45.1;CD45.2) cells from wild-type mice and transplanted to lethally irradiated recipient (CD45.1) mice ( n = 11-14 recipient mice/genotype from 3 donors/genotype). ( H ) Donor chimerism of mature cells in bone marrow, spleen and blood 12 days after CMP transplant.

    Article Snippet: Recipient mice (CD45.1) were lethally irradiated using an XRAD 320 X-ray irradiator (Precision X-Ray) with two doses of 5.4 Gy (10.8 Gy total) delivered at least 3 hours apart.

    Techniques: Activity Assay, Control, Transplantation Assay, Irradiation